Invalid Symbol

Stock Research for ENDP

ENDP
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ENDP Stock Chart & Research Data

The ENDP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ENDP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ENDP Due diligence Resources & Stock Charts

The ENDP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ENDP Detailed Price Forecast - CNN Money CNN View ENDP Detailed Summary - Google Finance
Yahoo View ENDP Detailed Summary - Yahoo! Finance Zacks View ENDP Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ENDP Trends & Analysis - Trade-Ideas Barrons View ENDP Major Holders - Barrons
NASDAQ View ENDP Call Transcripts - NASDAQ Seeking View ENDP Breaking News & Analysis - Seeking Alpha
Spotlight View ENDP Annual Report - CompanySpotlight.com OTC Report View ENDP OTC Short Report - OTCShortReport.com
TradeKing View ENDP Fundamentals - TradeKing Charts View ENDP SEC Filings - Bar Chart
WSJ View Historical Prices for ENDP - The WSJ Morningstar View Performance/Total Return for ENDP - Morningstar
MarketWatch View the Analyst Estimates for ENDP - MarketWatch CNBC View the Earnings History for ENDP - CNBC
StockMarketWatch View the ENDP Earnings - StockMarketWatch MacroAxis View ENDP Buy or Sell Recommendations - MacroAxis
Bullish View the ENDP Bullish Patterns - American Bulls Short Pains View ENDP Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ENDP Stock Mentions - StockTwits PennyStocks View ENDP Stock Mentions - PennyStockTweets
Twitter View ENDP Stock Mentions - Twitter Invest Hub View ENDP Investment Forum News - Investor Hub
Yahoo View ENDP Stock Mentions - Yahoo! Message Board Seeking Alpha View ENDP Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ENDP - SECform4.com Insider Cow View Insider Transactions for ENDP - Insider Cow
CNBC View ENDP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ENDP - OTC Markets
Yahoo View Insider Transactions for ENDP - Yahoo! Finance NASDAQ View Institutional Holdings for ENDP - NASDAQ


Stock Charts

FinViz View ENDP Stock Insight & Charts - FinViz.com StockCharts View ENDP Investment Charts - StockCharts.com
BarChart View ENDP Stock Overview & Charts - BarChart Trading View View ENDP User Generated Charts - Trading View


Latest Financial News for ENDP

See what the IHS Markit Score report has to say about Endo International PLC.
Posted on Monday February 12, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.


OxyContin maker stops promoting opioids, cuts sales staff
Posted on Saturday February 10, 2018

OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers. The drugmaker said it will inform doctors on Monday that its sales representatives will no longer visit physician offices to discuss its opioid products. It will now have about 200 sales representatives, Purdue said.


Endo begins late-stage testing of potential cellulite treatment
Posted on Wednesday February 07, 2018

Endo International said Tuesday it has initiated two phase-III clinical trials testing the ability of an existing product to treat cellulite. Cellulite, a condition that results in a localized alteration in the contour of the skin, afflicts 85 percent to 98 percent of women. The condition occurs when the layer of fat beneath the skin pushes against connective tissue and bulges creating the appearance of lumpy or dimpled skin.


Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite
Posted on Tuesday February 06, 2018

Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite


Endo International plc To Delist Ordinary Shares From The Toronto Stock Exchange
PR Newswire (press release) - Mar 3, 2017
DUBLIN, March 3, 2017 /PRNewswire/ -- Endo International plc (NASDAQ / TSX: ENDP) today announced that it has applied to the Toronto Stock Exchange (the "TSX") to have its ordinary shares delisted from the TSX at the close of business on March 17, 2017 ...
Top Analyst Boosts Price Target on Endo International plc – Ordinary Shares ... - Smarter Analyst

Endo International plc (ENDP) Analysts See $0.62 EPS
BZ Weekly - Feb 21, 2018
Bancorporation Of Hawaii reported 16,070 shares. Panagora Asset Mngmt Incorporated has 0% invested in Endo International plc (NASDAQ:ENDP). Arizona State Retirement Systems has 113,947 shares. Prelude Cap has invested 0.01% of its portfolio in Endo ...
Endo International plc (ENDP) EPS Estimated At $0.62 - Reurope

Endo International plc – Ordinary Shares (ENDP) Announces Q1:17 Results ...
Smarter Analyst - May 9, 2017
“During Endo's February 2017 earnings call, we outlined key priorities that we believe will enable us to achieve our Company's vision.

Endo International plc – Ordinary Shares (ENDP) Collapses Taking Hedge Fund ...
ValueWalk - May 6, 2016
We think ENDP needs to look at strategic alternatives at this point - there are equity combinations that could make sense. The challenge that ENDP now faces is that current P&L headwinds will take time to get through and in the interim, leverage ...
Endo Reports First Quarter 2016 Financial Results - PR Newswire (press release)

Enter a stock symbol to view the stock details.